New Enterprise Associates (NEA) is a global venture capital firm that funds technology and healthcare companies across all investment stages with more than $20 billion in committed capital since the firm's founding in 1977. The firm's long track record of successful investments includes more than 220 portfolio company IPOs and more than 370 portfolio company acquisitions.
As one of the world's largest and most active venture capital firms, NEA has developed deep domain expertise and insight into our industries of focus. We channel that knowledge into every technology and healthcare investment we make — at any stage, in any location, around the globe.
Across our portfolio, visionary entrepreneurs are at the helm of current and future industry leaders, fueling the development of technologies that will keep the US at the forefront of innovation. Some of the most successful business leaders in each of these industries have joined forces with NEA as Venture Partners, bringing tremendous sector insight and deep networks.
We've built a premier technology practice by fueling the growth of disruptive enterprise and consumer technology companies, helping to build market leaders across a wide swath of sectors including software, systems, services, security, mobility and commerce.
NEA's commitment to healthcare investing spans decades, a rarity in venture capital. Across biopharma, devices and healthcare services/IT, companies in our portfolio have pioneered transformative medical innovations like balloon angioplasty and laparoscopic surgery.
NEA's proven investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. Any stage of growth is the right stage to partner with NEA. We can add value and offer expert guidance throughout your company's lifecycle — whether your big idea is at its inception or has already progressed to be a viable reality.
At a global scale
The last two decades have marked the largest expansion of the global economy the world has ever seen, with more than half of the expansion attributable to emerging economies. With bi-coastal US operations and a growing international presence, NEA stays on the cutting edge of new technologies as we expand our global network.
Growing up on both coasts
Nearly 40 years ago, our founders formed the industry's first truly bi-coastal firm. Our US presence has grown to include offices in Menlo Park, San Francisco, New York, Boston and the Washington, DC metropolitan area. This enables NEA to find the best opportunities at the source of innovation, and to build a vast network of resources and expertise from coast to coast.
Built for global scale
NEA actively invests in emerging markets around the world. We are continuously expanding our global network to benefit companies in our portfolio — many of which are operating internationally from the earliest stages. Today our investing activities span five continents, and we think the world seems a little flatter every day.
How we work with DLA Piper
With dedicated teams of DLA Piper lawyers in each of the major technology and healthcare markets where NEA invests, DLA Piper supports NEA's investment team in providing legal advice to power the design, construction and execution of processes that enable sound investments in technology and healthcare companies in all stages of growth around the world.
Peter Barris, Chairman and General Partner
Forest Baskett, PhD, General Partner
Tony Florence, General Partner
Patrick Kerins, General Partner
Mohamad Makhazoumi, General Partner
Josh Makower, General Partner
David Mott, General Partner
Scott Sandell, Managing General Partner
Jon Sakoda, General Partner
Peter Sonsini, General Partner
Ravi Viswanathan, General Partner
Stephanie Brecher, General Counsel
Louis Citron, Chief Legal Officer